These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 10327046)
1. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system. Hammer-Wilson MJ; Ghahramanlou M; Berns MW Lasers Surg Med; 1999; 24(4):276-84. PubMed ID: 10327046 [TBL] [Abstract][Full Text] [Related]
2. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system. Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320 [TBL] [Abstract][Full Text] [Related]
3. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Young SW; Woodburn KW; Wright M; Mody TD; Fan Q; Sessler JL; Dow WC; Miller RA Photochem Photobiol; 1996 Jun; 63(6):892-7. PubMed ID: 8992510 [TBL] [Abstract][Full Text] [Related]
4. Phototherapy of cancer and atheromatous plaque with texaphyrins. Woodburn KW; Fan Q; Kessel D; Wright M; Mody TD; Hemmi G; Magda D; Sessler JL; Dow WC; Miller RA; Young SW J Clin Laser Med Surg; 1996 Oct; 14(5):343-8. PubMed ID: 9612202 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo comparison of argon-pumped and diode lasers for photodynamic therapy using second-generation photosensitizers. Hammer-Wilson MJ; Sun CH; Ghahramanlou M; Berns MW Lasers Surg Med; 1998; 23(5):274-80. PubMed ID: 9888323 [TBL] [Abstract][Full Text] [Related]
6. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Korbelik M; Sun J; Posakony JJ Photochem Photobiol; 2001 Apr; 73(4):403-9. PubMed ID: 11332036 [TBL] [Abstract][Full Text] [Related]
7. Effects of photodynamic therapy on adhesion molecules and metastasis. Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074 [TBL] [Abstract][Full Text] [Related]
9. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model. Li LB; Luo RC Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells. Chang CJ; Yu JS; Wei FC Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study. Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy. Karotki A; Khurana M; Lepock JR; Wilson BC Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497 [TBL] [Abstract][Full Text] [Related]
13. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. Verigos K; Stripp DC; Mick R; Zhu TC; Whittington R; Smith D; Dimofte A; Finlay J; Busch TM; Tochner ZA; Malkowicz S; Glatstein E; Hahn SM J Environ Pathol Toxicol Oncol; 2006; 25(1-2):373-87. PubMed ID: 16566729 [TBL] [Abstract][Full Text] [Related]
14. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine. Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Lilge L; Wilson BC J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. Woodburn KW; Fan Q; Kessel D; Luo Y; Young SW J Invest Dermatol; 1998 May; 110(5):746-51. PubMed ID: 9579539 [TBL] [Abstract][Full Text] [Related]
17. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Sitnik TM; Henderson BW Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590 [TBL] [Abstract][Full Text] [Related]
18. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Woodburn KW; Fan Q; Miles DR; Kessel D; Luo Y; Young SW Photochem Photobiol; 1997 Mar; 65(3):410-5. PubMed ID: 9077121 [TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]